China’s Government Might Phase Out Ad Hoc Price Controls On Drugs
This article was originally published in PharmAsia News
Executive Summary
BEIJING - China's National Development and Reform Commission is mulling proposals to phase out its fluctuating and sometimes opaque price control policies on pharmaceuticals in favor of a more rational and open system, according to an analyst briefed on the issue